Jornadas held a new scientific session at SOLACI-SOCIME 2025

During the SOLACI-SOCIME 2025 Congress, the largest interventional cardiology event in Latin America, a notable scientific session was held, organized by the Jornadas SOLACI area, focused on the management of complex coronary artery disease. The session addressed key clinical and therapeutic aspects in the treatment of this type of disease and featured high-level speakers who shared their expertise and knowledge.

Jornadas SOLACI-SOCIME 2025

The session was coordinated by Ricardo Coloma (Peru) and included contributions from prominent specialists such as Gustavo Vignolo and Pablo Vázquez (Uruguay).

The program began with Erick Hornez (Bolivia), who presented Management of Left Main Coronary Artery Lesions: How Much Have We Learned?, updating the audience on the most effective strategies for treating these highly complex lesions. Next, Pedro Hidalgo (Venezuela) addressed Management of Calcified Lesions: What Tools Do We Have Today?, delving into the latest approaches and devices for treating calcified coronary artery lesions. Sebastián Lluberas (Uruguay) then presented The Drug-Coated Balloon and Its Current Indications, highlighting advancements in the use of drug-coated balloons and their applicability in coronary intervention.

The next presentation, by Gustavo Hidalgo (Ecuador), focused on Revascularization of Chronic Total Occlusions, outlining the most effective techniques for treating severe blockages in the coronary arteries. Finally, Pablo Vázquez (Uruguay) presented a Clinical Case, detailing a real-life challenge in the treatment of complex coronary artery disease, followed by an in-depth analysis of its resolution.

The session concluded with a discussion period, where the speakers exchanged insights and answered audience questions, reinforcing dialogue around the advances and challenges in the treatment of complex coronary artery disease.

This meeting highlighted the academic quality of the SOLACI-SOCIME 2025 Congress and reaffirmed the commitment of the Jornadas SOLACI area to continuing medical education and the ongoing development of healthcare professionals in interventional cardiology across Latin America.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

Fellow’s Corner 2026 – Submit Your Clinical Case

Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...